These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 34732776)

  • 1. Developmental defects and impaired network excitability in a cerebral organoid model of KCNJ11 p.V59M-related neonatal diabetes.
    Dalgin G; Tryba AK; Cohen AP; Park SY; Philipson LH; Greeley SAW; Garcia AJ
    Sci Rep; 2021 Nov; 11(1):21590. PubMed ID: 34732776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of an activating mutation in the gene encoding the KATP channel subunit Kir6.2 in mouse pancreatic beta cells recapitulates neonatal diabetes.
    Girard CA; Wunderlich FT; Shimomura K; Collins S; Kaizik S; Proks P; Abdulkader F; Clark A; Ball V; Zubcevic L; Bentley L; Clark R; Church C; Hugill A; Galvanovskis J; Cox R; Rorsman P; Brüning JC; Ashcroft FM
    J Clin Invest; 2009 Jan; 119(1):80-90. PubMed ID: 19065048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features.
    Gloyn AL; Diatloff-Zito C; Edghill EL; Bellanné-Chantelot C; Nivot S; Coutant R; Ellard S; Hattersley AT; Robert JJ
    Eur J Hum Genet; 2006 Jul; 14(7):824-30. PubMed ID: 16670688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and clinical features of K
    Hashimoto Y; Dateki S; Hirose M; Satomura K; Sawada H; Mizuno H; Sugihara S; Maruyama K; Urakami T; Sugawara H; Shirai K; Yorifuji T
    Pediatr Diabetes; 2017 Nov; 18(7):532-539. PubMed ID: 27681997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychiatric morbidity in children with KCNJ11 neonatal diabetes.
    Bowman P; Broadbridge E; Knight BA; Pettit L; Flanagan SE; Reville M; Tonks J; Shepherd MH; Ford TJ; Hattersley AT
    Diabet Med; 2016 Oct; 33(10):1387-91. PubMed ID: 27086753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved motor development and good long-term glycaemic control with sulfonylurea treatment in a patient with the syndrome of intermediate developmental delay, early-onset generalised epilepsy and neonatal diabetes associated with the V59M mutation in the KCNJ11 gene.
    Slingerland AS; Nuboer R; Hadders-Algra M; Hattersley AT; Bruining GJ
    Diabetologia; 2006 Nov; 49(11):2559-63. PubMed ID: 17047922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Genetics, Clinical Characteristics, and Treatment Outcomes of K
    Ngoc CTB; Dien TM; De Franco E; Ellard S; Houghton JAL; Lan NN; Thao BP; Khanh NN; Flanagan SE; Craig ME; Dung VC
    Front Endocrinol (Lausanne); 2021; 12():727083. PubMed ID: 34566892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterization of a novel KCNJ11 in frame mutation-deletion associated with infancy-onset diabetes and a mild form of intermediate DEND: a battle between K(ATP) gain of channel activity and loss of channel expression.
    Lin YW; Li A; Grasso V; Battaglia D; Crinò A; Colombo C; Barbetti F; Nichols CG
    PLoS One; 2013; 8(5):e63758. PubMed ID: 23667671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional effects of KCNJ11 mutations causing neonatal diabetes: enhanced activation by MgATP.
    Proks P; Girard C; Ashcroft FM
    Hum Mol Genet; 2005 Sep; 14(18):2717-26. PubMed ID: 16087682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype.
    Flanagan SE; Edghill EL; Gloyn AL; Ellard S; Hattersley AT
    Diabetologia; 2006 Jun; 49(6):1190-7. PubMed ID: 16609879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visuomotor performance in KCNJ11-related neonatal diabetes is impaired in children with DEND-associated mutations and may be improved by early treatment with sulfonylureas.
    Shah RP; Spruyt K; Kragie BC; Greeley SA; Msall ME
    Diabetes Care; 2012 Oct; 35(10):2086-8. PubMed ID: 22855734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The G53D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes and motor dysfunction in adulthood that is improved with sulfonylurea therapy.
    Koster JC; Cadario F; Peruzzi C; Colombo C; Nichols CG; Barbetti F
    J Clin Endocrinol Metab; 2008 Mar; 93(3):1054-61. PubMed ID: 18073297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An in-frame deletion in Kir6.2 (KCNJ11) causing neonatal diabetes reveals a site of interaction between Kir6.2 and SUR1.
    Craig TJ; Shimomura K; Holl RW; Flanagan SE; Ellard S; Ashcroft FM
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2551-7. PubMed ID: 19351728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes.
    Massa O; Iafusco D; D'Amato E; Gloyn AL; Hattersley AT; Pasquino B; Tonini G; Dammacco F; Zanette G; Meschi F; Porzio O; Bottazzo G; Crinó A; Lorini R; Cerutti F; Vanelli M; Barbetti F;
    Hum Mutat; 2005 Jan; 25(1):22-7. PubMed ID: 15580558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle dysfunction caused by a KATP channel mutation in neonatal diabetes is neuronal in origin.
    Clark RH; McTaggart JS; Webster R; Mannikko R; Iberl M; Sim XL; Rorsman P; Glitsch M; Beeson D; Ashcroft FM
    Science; 2010 Jul; 329(5990):458-61. PubMed ID: 20595581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal diabetes mellitus: description of two Puerto Rican children with KCNJ11 activating gene mutation.
    Nieves-Rivera F; González-Pijem L
    P R Health Sci J; 2011 Jun; 30(2):87-9. PubMed ID: 21682153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into K
    Pipatpolkai T; Usher S; Stansfeld PJ; Ashcroft FM
    Nat Rev Endocrinol; 2020 Jul; 16(7):378-393. PubMed ID: 32376986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intellectual Disability in K
    Svalastoga P; Sulen Å; Fehn JR; Aukland SM; Irgens H; Sirnes E; Fevang SKE; Valen E; Elgen IB; Njølstad PR
    Diabetes Care; 2020 Mar; 43(3):526-533. PubMed ID: 31932458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Permanent neonatal diabetes due to activating mutations in ABCC8 and KCNJ11.
    Edghill EL; Flanagan SE; Ellard S
    Rev Endocr Metab Disord; 2010 Sep; 11(3):193-8. PubMed ID: 20922570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical and developmental impact of transition from subcutaneous insulin to oral glyburide in a 15-yr-old boy with neonatal diabetes mellitus and intermediate DEND syndrome: extending the age of KCNJ11 mutation testing in neonatal DM.
    Mohamadi A; Clark LM; Lipkin PH; Mahone EM; Wodka EL; Plotnick LP
    Pediatr Diabetes; 2010 May; 11(3):203-7. PubMed ID: 19686306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.